The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global mRNA Flu Vaccine Market Research Report 2025
Synopsis
The global mRNA Flu Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for mRNA Flu Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for mRNA Flu Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of mRNA Flu Vaccine include Moderna, BioNTech, CureVac, Novavax, Sanofi, Inovio Pharmaceuticals, Arcturus Therapeutics Holdings, eTheRNA immunotherapies, Valneva, Vaxart, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for mRNA Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Flu Vaccine.
The mRNA Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global mRNA Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Moderna
BioNTech
CureVac
Novavax
Sanofi
Inovio Pharmaceuticals
Arcturus Therapeutics Holdings
eTheRNA immunotherapies
Valneva
Vaxart
Entos Pharmaceuticals
Abnova Corporation
Anima Biotech
Sarepta Therapeutics
iBio
Barinthus Biotherapeutics
Alnylam Pharmaceuticals
Beam Therapeutics
Segment by Type
mRNA-1010
mRNA-1020
mRNA-1030
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of mRNA Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of mRNA Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global mRNA Flu Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for mRNA Flu Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for mRNA Flu Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of mRNA Flu Vaccine include Moderna, BioNTech, CureVac, Novavax, Sanofi, Inovio Pharmaceuticals, Arcturus Therapeutics Holdings, eTheRNA immunotherapies, Valneva, Vaxart, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for mRNA Flu Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding mRNA Flu Vaccine.
The mRNA Flu Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global mRNA Flu Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the mRNA Flu Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
Moderna
BioNTech
CureVac
Novavax
Sanofi
Inovio Pharmaceuticals
Arcturus Therapeutics Holdings
eTheRNA immunotherapies
Valneva
Vaxart
Entos Pharmaceuticals
Abnova Corporation
Anima Biotech
Sarepta Therapeutics
iBio
Barinthus Biotherapeutics
Alnylam Pharmaceuticals
Beam Therapeutics
Segment by Type
mRNA-1010
mRNA-1020
mRNA-1030
Segment by Application
Hospital
Clinic
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of mRNA Flu Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of mRNA Flu Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 mRNA Flu Vaccine Market Overview
1.1 Product Definition
1.2 mRNA Flu Vaccine by Type
1.2.1 Global mRNA Flu Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 mRNA-1010
1.2.3 mRNA-1020
1.2.4 mRNA-1030
1.3 mRNA Flu Vaccine by Application
1.3.1 Global mRNA Flu Vaccine Market Value by Application (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global mRNA Flu Vaccine Market Size Estimates and Forecasts
1.4.1 Global mRNA Flu Vaccine Revenue 2019-2030
1.4.2 Global mRNA Flu Vaccine Sales 2019-2030
1.4.3 Global mRNA Flu Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 mRNA Flu Vaccine Market Competition by Manufacturers
2.1 Global mRNA Flu Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global mRNA Flu Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global mRNA Flu Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Key Players of mRNA Flu Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of mRNA Flu Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of mRNA Flu Vaccine, Product Type & Application
2.7 Global Key Manufacturers of mRNA Flu Vaccine, Date of Enter into This Industry
2.8 Global mRNA Flu Vaccine Market Competitive Situation and Trends
2.8.1 Global mRNA Flu Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest mRNA Flu Vaccine Players Market Share by Revenue
2.8.3 Global mRNA Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global mRNA Flu Vaccine Market Scenario by Region
3.1 Global mRNA Flu Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global mRNA Flu Vaccine Sales by Region: 2019-2030
3.2.1 Global mRNA Flu Vaccine Sales by Region: 2019-2024
3.2.2 Global mRNA Flu Vaccine Sales by Region: 2025-2030
3.3 Global mRNA Flu Vaccine Revenue by Region: 2019-2030
3.3.1 Global mRNA Flu Vaccine Revenue by Region: 2019-2024
3.3.2 Global mRNA Flu Vaccine Revenue by Region: 2025-2030
3.4 North America mRNA Flu Vaccine Market Facts & Figures by Country
3.4.1 North America mRNA Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America mRNA Flu Vaccine Sales by Country (2019-2030)
3.4.3 North America mRNA Flu Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe mRNA Flu Vaccine Market Facts & Figures by Country
3.5.1 Europe mRNA Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe mRNA Flu Vaccine Sales by Country (2019-2030)
3.5.3 Europe mRNA Flu Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific mRNA Flu Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific mRNA Flu Vaccine Market Size by Region: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific mRNA Flu Vaccine Sales by Region (2019-2030)
3.6.3 Asia Pacific mRNA Flu Vaccine Revenue by Region (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America mRNA Flu Vaccine Market Facts & Figures by Country
3.7.1 Latin America mRNA Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America mRNA Flu Vaccine Sales by Country (2019-2030)
3.7.3 Latin America mRNA Flu Vaccine Revenue by Country
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa mRNA Flu Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa mRNA Flu Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa mRNA Flu Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa mRNA Flu Vaccine Revenue by Country
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global mRNA Flu Vaccine Sales by Type (2019-2030)
4.1.1 Global mRNA Flu Vaccine Sales by Type (2019-2024)
4.1.2 Global mRNA Flu Vaccine Sales by Type (2025-2030)
4.1.3 Global mRNA Flu Vaccine Sales Market Share by Type (2019-2030)
4.2 Global mRNA Flu Vaccine Revenue by Type (2019-2030)
4.2.1 Global mRNA Flu Vaccine Revenue by Type (2019-2024)
4.2.2 Global mRNA Flu Vaccine Revenue by Type (2025-2030)
4.2.3 Global mRNA Flu Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global mRNA Flu Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global mRNA Flu Vaccine Sales by Application (2019-2030)
5.1.1 Global mRNA Flu Vaccine Sales by Application (2019-2024)
5.1.2 Global mRNA Flu Vaccine Sales by Application (2025-2030)
5.1.3 Global mRNA Flu Vaccine Sales Market Share by Application (2019-2030)
5.2 Global mRNA Flu Vaccine Revenue by Application (2019-2030)
5.2.1 Global mRNA Flu Vaccine Revenue by Application (2019-2024)
5.2.2 Global mRNA Flu Vaccine Revenue by Application (2025-2030)
5.2.3 Global mRNA Flu Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global mRNA Flu Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Moderna
6.1.1 Moderna Company Information
6.1.2 Moderna Description and Business Overview
6.1.3 Moderna mRNA Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Moderna mRNA Flu Vaccine Product Portfolio
6.1.5 Moderna Recent Developments/Updates
6.2 BioNTech
6.2.1 BioNTech Company Information
6.2.2 BioNTech Description and Business Overview
6.2.3 BioNTech mRNA Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 BioNTech mRNA Flu Vaccine Product Portfolio
6.2.5 BioNTech Recent Developments/Updates
6.3 CureVac
6.3.1 CureVac Company Information
6.3.2 CureVac Description and Business Overview
6.3.3 CureVac mRNA Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 CureVac mRNA Flu Vaccine Product Portfolio
6.3.5 CureVac Recent Developments/Updates
6.4 Novavax
6.4.1 Novavax Company Information
6.4.2 Novavax Description and Business Overview
6.4.3 Novavax mRNA Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Novavax mRNA Flu Vaccine Product Portfolio
6.4.5 Novavax Recent Developments/Updates
6.5 Sanofi
6.5.1 Sanofi Company Information
6.5.2 Sanofi Description and Business Overview
6.5.3 Sanofi mRNA Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Sanofi mRNA Flu Vaccine Product Portfolio
6.5.5 Sanofi Recent Developments/Updates
6.6 Inovio Pharmaceuticals
6.6.1 Inovio Pharmaceuticals Company Information
6.6.2 Inovio Pharmaceuticals Description and Business Overview
6.6.3 Inovio Pharmaceuticals mRNA Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Inovio Pharmaceuticals mRNA Flu Vaccine Product Portfolio
6.6.5 Inovio Pharmaceuticals Recent Developments/Updates
6.7 Arcturus Therapeutics Holdings
6.7.1 Arcturus Therapeutics Holdings Company Information
6.7.2 Arcturus Therapeutics Holdings Description and Business Overview
6.7.3 Arcturus Therapeutics Holdings mRNA Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.7.4 Arcturus Therapeutics Holdings mRNA Flu Vaccine Product Portfolio
6.7.5 Arcturus Therapeutics Holdings Recent Developments/Updates
6.8 eTheRNA immunotherapies
6.8.1 eTheRNA immunotherapies Company Information
6.8.2 eTheRNA immunotherapies Description and Business Overview
6.8.3 eTheRNA immunotherapies mRNA Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 eTheRNA immunotherapies mRNA Flu Vaccine Product Portfolio
6.8.5 eTheRNA immunotherapies Recent Developments/Updates
6.9 Valneva
6.9.1 Valneva Company Information
6.9.2 Valneva Description and Business Overview
6.9.3 Valneva mRNA Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Valneva mRNA Flu Vaccine Product Portfolio
6.9.5 Valneva Recent Developments/Updates
6.10 Vaxart
6.10.1 Vaxart Company Information
6.10.2 Vaxart Description and Business Overview
6.10.3 Vaxart mRNA Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Vaxart mRNA Flu Vaccine Product Portfolio
6.10.5 Vaxart Recent Developments/Updates
6.11 Entos Pharmaceuticals
6.11.1 Entos Pharmaceuticals Company Information
6.11.2 Entos Pharmaceuticals Description and Business Overview
6.11.3 Entos Pharmaceuticals mRNA Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Entos Pharmaceuticals mRNA Flu Vaccine Product Portfolio
6.11.5 Entos Pharmaceuticals Recent Developments/Updates
6.12 Abnova Corporation
6.12.1 Abnova Corporation Company Information
6.12.2 Abnova Corporation Description and Business Overview
6.12.3 Abnova Corporation mRNA Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Abnova Corporation mRNA Flu Vaccine Product Portfolio
6.12.5 Abnova Corporation Recent Developments/Updates
6.13 Anima Biotech
6.13.1 Anima Biotech Company Information
6.13.2 Anima Biotech Description and Business Overview
6.13.3 Anima Biotech mRNA Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Anima Biotech mRNA Flu Vaccine Product Portfolio
6.13.5 Anima Biotech Recent Developments/Updates
6.14 Sarepta Therapeutics
6.14.1 Sarepta Therapeutics Company Information
6.14.2 Sarepta Therapeutics Description and Business Overview
6.14.3 Sarepta Therapeutics mRNA Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Sarepta Therapeutics mRNA Flu Vaccine Product Portfolio
6.14.5 Sarepta Therapeutics Recent Developments/Updates
6.15 iBio
6.15.1 iBio Company Information
6.15.2 iBio Description and Business Overview
6.15.3 iBio mRNA Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.15.4 iBio mRNA Flu Vaccine Product Portfolio
6.15.5 iBio Recent Developments/Updates
6.16 Barinthus Biotherapeutics
6.16.1 Barinthus Biotherapeutics Company Information
6.16.2 Barinthus Biotherapeutics Description and Business Overview
6.16.3 Barinthus Biotherapeutics mRNA Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.16.4 Barinthus Biotherapeutics mRNA Flu Vaccine Product Portfolio
6.16.5 Barinthus Biotherapeutics Recent Developments/Updates
6.17 Alnylam Pharmaceuticals
6.17.1 Alnylam Pharmaceuticals Company Information
6.17.2 Alnylam Pharmaceuticals Description and Business Overview
6.17.3 Alnylam Pharmaceuticals mRNA Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.17.4 Alnylam Pharmaceuticals mRNA Flu Vaccine Product Portfolio
6.17.5 Alnylam Pharmaceuticals Recent Developments/Updates
6.18 Beam Therapeutics
6.18.1 Beam Therapeutics Company Information
6.18.2 Beam Therapeutics Description and Business Overview
6.18.3 Beam Therapeutics mRNA Flu Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.18.4 Beam Therapeutics mRNA Flu Vaccine Product Portfolio
6.18.5 Beam Therapeutics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 mRNA Flu Vaccine Industry Chain Analysis
7.2 mRNA Flu Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 mRNA Flu Vaccine Production Mode & Process
7.4 mRNA Flu Vaccine Sales and Marketing
7.4.1 mRNA Flu Vaccine Sales Channels
7.4.2 mRNA Flu Vaccine Distributors
7.5 mRNA Flu Vaccine Customers
8 mRNA Flu Vaccine Market Dynamics
8.1 mRNA Flu Vaccine Industry Trends
8.2 mRNA Flu Vaccine Market Drivers
8.3 mRNA Flu Vaccine Market Challenges
8.4 mRNA Flu Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global mRNA Flu Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global mRNA Flu Vaccine Market Value by Application (2024-2030) & (US$ Million)
Table 3. Global mRNA Flu Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global mRNA Flu Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global mRNA Flu Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global mRNA Flu Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global mRNA Flu Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market mRNA Flu Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of mRNA Flu Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of mRNA Flu Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of mRNA Flu Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of mRNA Flu Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global mRNA Flu Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in mRNA Flu Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global mRNA Flu Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global mRNA Flu Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global mRNA Flu Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global mRNA Flu Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global mRNA Flu Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global mRNA Flu Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global mRNA Flu Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global mRNA Flu Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global mRNA Flu Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America mRNA Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America mRNA Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America mRNA Flu Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America mRNA Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America mRNA Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe mRNA Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe mRNA Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe mRNA Flu Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe mRNA Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe mRNA Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific mRNA Flu Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific mRNA Flu Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific mRNA Flu Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific mRNA Flu Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific mRNA Flu Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America mRNA Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America mRNA Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America mRNA Flu Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America mRNA Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America mRNA Flu Vaccine Revenue Market Share by Country (2019-2024)
Table 45. Middle East and Africa mRNA Flu Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East and Africa mRNA Flu Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East and Africa mRNA Flu Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East and Africa mRNA Flu Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East and Africa mRNA Flu Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global mRNA Flu Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global mRNA Flu Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global mRNA Flu Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global mRNA Flu Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global mRNA Flu Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global mRNA Flu Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global mRNA Flu Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global mRNA Flu Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global mRNA Flu Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global mRNA Flu Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global mRNA Flu Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global mRNA Flu Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global mRNA Flu Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global mRNA Flu Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global mRNA Flu Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global mRNA Flu Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global mRNA Flu Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global mRNA Flu Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global mRNA Flu Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global mRNA Flu Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. Moderna Company Information
Table 71. Moderna Description and Business Overview
Table 72. Moderna mRNA Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Moderna mRNA Flu Vaccine Product
Table 74. Moderna Recent Developments/Updates
Table 75. BioNTech Company Information
Table 76. BioNTech Description and Business Overview
Table 77. BioNTech mRNA Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. BioNTech mRNA Flu Vaccine Product
Table 79. BioNTech Recent Developments/Updates
Table 80. CureVac Company Information
Table 81. CureVac Description and Business Overview
Table 82. CureVac mRNA Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. CureVac mRNA Flu Vaccine Product
Table 84. CureVac Recent Developments/Updates
Table 85. Novavax Company Information
Table 86. Novavax Description and Business Overview
Table 87. Novavax mRNA Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Novavax mRNA Flu Vaccine Product
Table 89. Novavax Recent Developments/Updates
Table 90. Sanofi Company Information
Table 91. Sanofi Description and Business Overview
Table 92. Sanofi mRNA Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Sanofi mRNA Flu Vaccine Product
Table 94. Sanofi Recent Developments/Updates
Table 95. Inovio Pharmaceuticals Company Information
Table 96. Inovio Pharmaceuticals Description and Business Overview
Table 97. Inovio Pharmaceuticals mRNA Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Inovio Pharmaceuticals mRNA Flu Vaccine Product
Table 99. Inovio Pharmaceuticals Recent Developments/Updates
Table 100. Arcturus Therapeutics Holdings Company Information
Table 101. Arcturus Therapeutics Holdings Description and Business Overview
Table 102. Arcturus Therapeutics Holdings mRNA Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Arcturus Therapeutics Holdings mRNA Flu Vaccine Product
Table 104. Arcturus Therapeutics Holdings Recent Developments/Updates
Table 105. eTheRNA immunotherapies Company Information
Table 106. eTheRNA immunotherapies Description and Business Overview
Table 107. eTheRNA immunotherapies mRNA Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. eTheRNA immunotherapies mRNA Flu Vaccine Product
Table 109. eTheRNA immunotherapies Recent Developments/Updates
Table 110. Valneva Company Information
Table 111. Valneva Description and Business Overview
Table 112. Valneva mRNA Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Valneva mRNA Flu Vaccine Product
Table 114. Valneva Recent Developments/Updates
Table 115. Vaxart Company Information
Table 116. Vaxart Description and Business Overview
Table 117. Vaxart mRNA Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Vaxart mRNA Flu Vaccine Product
Table 119. Vaxart Recent Developments/Updates
Table 120. Entos Pharmaceuticals Company Information
Table 121. Entos Pharmaceuticals Description and Business Overview
Table 122. Entos Pharmaceuticals mRNA Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Entos Pharmaceuticals mRNA Flu Vaccine Product
Table 124. Entos Pharmaceuticals Recent Developments/Updates
Table 125. Abnova Corporation Company Information
Table 126. Abnova Corporation Description and Business Overview
Table 127. Abnova Corporation mRNA Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Abnova Corporation mRNA Flu Vaccine Product
Table 129. Abnova Corporation Recent Developments/Updates
Table 130. Anima Biotech Company Information
Table 131. Anima Biotech Description and Business Overview
Table 132. Anima Biotech mRNA Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Anima Biotech mRNA Flu Vaccine Product
Table 134. Anima Biotech Recent Developments/Updates
Table 135. Sarepta Therapeutics Company Information
Table 136. Sarepta Therapeutics Description and Business Overview
Table 137. Sarepta Therapeutics mRNA Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Sarepta Therapeutics mRNA Flu Vaccine Product
Table 139. Sarepta Therapeutics Recent Developments/Updates
Table 140. iBio Company Information
Table 141. iBio Description and Business Overview
Table 142. iBio mRNA Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. iBio mRNA Flu Vaccine Product
Table 144. iBio Recent Developments/Updates
Table 145. Barinthus Biotherapeutics Company Information
Table 146. Barinthus Biotherapeutics Description and Business Overview
Table 147. Barinthus Biotherapeutics mRNA Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 148. Barinthus Biotherapeutics mRNA Flu Vaccine Product
Table 149. Barinthus Biotherapeutics Recent Developments/Updates
Table 150. Alnylam Pharmaceuticals Company Information
Table 151. Alnylam Pharmaceuticals Description and Business Overview
Table 152. Alnylam Pharmaceuticals mRNA Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 153. Alnylam Pharmaceuticals mRNA Flu Vaccine Product
Table 154. Alnylam Pharmaceuticals Recent Developments/Updates
Table 155. Beam Therapeutics Company Information
Table 156. Beam Therapeutics Description and Business Overview
Table 157. Beam Therapeutics mRNA Flu Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 158. Beam Therapeutics mRNA Flu Vaccine Product
Table 159. Beam Therapeutics Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. mRNA Flu Vaccine Distributors List
Table 163. mRNA Flu Vaccine Customers List
Table 164. mRNA Flu Vaccine Market Trends
Table 165. mRNA Flu Vaccine Market Drivers
Table 166. mRNA Flu Vaccine Market Challenges
Table 167. mRNA Flu Vaccine Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
Table 171. Authors List of This Report
List of Figures
Figure 1. Product Picture of mRNA Flu Vaccine
Figure 2. Global mRNA Flu Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global mRNA Flu Vaccine Market Share by Type: 2023 & 2030
Figure 4. mRNA-1010 Product Picture
Figure 5. mRNA-1020 Product Picture
Figure 6. mRNA-1030 Product Picture
Figure 7. Global mRNA Flu Vaccine Market Value by Application (2024-2030) & (US$ Million)
Figure 8. Global mRNA Flu Vaccine Market Share by Application: 2023 & 2030
Figure 9. Hospital
Figure 10. Clinic
Figure 11. Other
Figure 12. Global mRNA Flu Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global mRNA Flu Vaccine Market Size (2019-2030) & (US$ Million)
Figure 14. Global mRNA Flu Vaccine Sales (2019-2030) & (K Units)
Figure 15. Global mRNA Flu Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 16. mRNA Flu Vaccine Report Years Considered
Figure 17. mRNA Flu Vaccine Sales Share by Manufacturers in 2023
Figure 18. Global mRNA Flu Vaccine Revenue Share by Manufacturers in 2023
Figure 19. Global 5 and 10 Largest mRNA Flu Vaccine Players: Market Share by Revenue in mRNA Flu Vaccine in 2023
Figure 20. mRNA Flu Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 21. Global mRNA Flu Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America mRNA Flu Vaccine Sales Market Share by Country (2019-2030)
Figure 23. North America mRNA Flu Vaccine Revenue Market Share by Country (2019-2030)
Figure 24. United States mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe mRNA Flu Vaccine Sales Market Share by Country (2019-2030)
Figure 27. Europe mRNA Flu Vaccine Revenue Market Share by Country (2019-2030)
Figure 28. Germany mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific mRNA Flu Vaccine Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific mRNA Flu Vaccine Revenue Market Share by Region (2019-2030)
Figure 35. China mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Latin America mRNA Flu Vaccine Sales Market Share by Country (2019-2030)
Figure 43. Mexico mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Brazil mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Argentina mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Colombia mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Middle East and Africa mRNA Flu Vaccine Sales Market Share by Country (2019-2030)
Figure 48. Middle East and Africa mRNA Flu Vaccine Revenue Market Share by Country (2019-2030)
Figure 49. Turkey mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Saudi Arabia mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. UAE mRNA Flu Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Global Sales Market Share of mRNA Flu Vaccine by Type (2019-2030)
Figure 53. Global Revenue Market Share of mRNA Flu Vaccine by Type (2019-2030)
Figure 54. Global mRNA Flu Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 55. Global Sales Market Share of mRNA Flu Vaccine by Application (2019-2030)
Figure 56. Global Revenue Market Share of mRNA Flu Vaccine by Application (2019-2030)
Figure 57. Global mRNA Flu Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 58. mRNA Flu Vaccine Value Chain
Figure 59. mRNA Flu Vaccine Production Process
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
